Practice note issued by the The Actuarial Equivalence PDP/MA-PD Practice Note Work Group on the actuarial equivalence for private prescription drug plans under Medicare Part D. The practice note addresses the procedural and professional aspects that require certification by CMS of an Academy member that a prescription drug plan or Medicare Advantage prescription drug plan meets the actuarial equivalence standard. (
)
Medicare Steering Committee monograph highlighting various potential approaches for addressing Medicare's financial problems, along with a discussion of their relative strengths and weaknesses. The report also provides an overview of how Medicare is funded and its financial status. (
)
Medicare Part D RBC Subgroup revision proposals to the NAIC life and health RBC instructions for Medicare Part D to address a potential unintended consequence related to the Authorized Control Level (ACL) RBC results. (
)
Medicare Part D RBC Subgroup comment letter to NAIC's Health Risk Based Capital Working Group on a possible update of proposed risk factors previously developed by the Academy's Medicare Part D subgroup. (
)
Part D Lessons Learned Work Group comment letter on what has worked well and what has not in Medicare Part D. The letter also offers recommendations to improve the overall operation and administration of the Part D program, specifically including the bidding process, management of eligibility, and coordination with Medicaid and with the Social Security Administration. (
)
Health Practice Council comments that urge CMS to reconsider the one-role-per-user rule for actuaries for Part D attestations and to investigate alternatives that would not prevent actuaries from fulfilling their actuarial obligations. (
)
Medicare Supplement Work Group comments to NAIC's Medigap Modernization Subgroup of the Senior Issues Task Force identifying potential transitional issues that will need to be addressed as part of Medicare Supplement modernization that the Subgroup has recently taken up. (
)
Practice note created by the Actuarial Equivalence Retiree Practice Note Work Group providing advisory guidance to actuaries attesting to the actuarial equivalence of a plan sponsor's retiree health plans for payments to sponsors of retiree prescription drug plans. (
)
Medicare Part D RBC subgroup report to the NAIC on proposed RBC risk factors relating to the insurance of Medicare Part D coverage commencing January 1, 2006. This report was written in response to a charge from the NAIC. (
)
Health Care Quality Work Group issue brief exploring definitions and measures of health care quality and examining the pay for performance approach to rewarding improvements in quality, particularly in the Medicare program. (
)
Memo to the NAIC from the Medicare Part D Subgroup with proposed health RBC instruction and health RBC formula changes, proposed life RBC instruction and life RBC formula changes, and explanatory slides.
(
)
Health RBC Subgroup status report to the NAIC Task Force. The subgroup was created in response to and NAIC charge for recommendations of changes to the 2006 RBC Formulas and Instructions, in order to address the risks of Medicare Part D Prescription Drug coverage. (
)
Cori E. Uccello and Ron Gebhardtsbauer Capitol Hill briefing regarding the 2005 trustees report, for Medicare and Social Security, demographic changes affecting both programs, and solvency issues. (
)
Letter offers the Academy as a resource on health care issues and shares some recent publications on key issues including Medicare and the uninsured. (
)
Academy comment letter recommending to Congress that individuals serving in the positions of SSA and CMS chief actuary be members in good standing of the American Academy of Actuaries. (
)
Senior Health Fellow issue brief outlining areas in which action, beyond the addition of the Medicare Part D program, could be taken to reform the Medicare program, including addressing long- term financing problems, balancing access to care while avoiding unnecessary utilization, private sector competition strategies, and addressing the insurance needs of individuals age 55 to 64. (
)
Medicare Steering Committee letter discusses issues related to eligibility and enrollment, benefits and beneficiary protections, submission of bids and monthly beneficiary premiums, payments to prescription drug plan sponsors and Medicare Advantage (MA) organizations, etc. Comments on issues related to actuarial equivalence in a separate letter. (
)